PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Infectious Diseases, Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA.\', \'Pulmonary Medicine, Atlanta Veterans Affairs Medical Center, Department of Medicine, Decatur, Georgia, USA.\', \'Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University, Atlanta, Georgia, USA.\', \'Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.\', \'Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa879
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32597466
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all